Advertisement Derma Sciences to introduce Xtrasorb super absorbent dressing - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Derma Sciences to introduce Xtrasorb super absorbent dressing

Derma Sciences, a manufacturer and marketer of advanced wound-care products, has announced the commercial launch of its new product - Xtrasorb super absorbent dressing.

The novel dressing features a polymer-based core that could help change the way clinicians manage heavily exuding wounds, currently a significant issue in wound care.

Ed Quilty, CEO of Derma Sciences, said: “This is something we have been excited about for quite a while. Foam dressings, for highly exuding wounds, is the single largest category of moist wound dressings, with over $300 million in global sales. Still, even the best dressings in this category have limitations. Clinicians still want dressings to hold more fluid to reduce the number of time-consuming and costly dressing changes. Additionally, the fluid that a foam dressing does absorb is at a high risk of being pushed back onto the wound bed, potentially causing serious complications to the wound.

“For these reasons, our market research shows that clinicians will love the fact that Xtrasorb can absorb roughly 50% more than even the most absorbent foam dressing, and that the polymer-based super-absorbent core forms a gel which locks all the wound fluid inside the dressing and away from the wound. This has multiple benefits, including reducing the risk of wound breakdown due to excessive moisture, as well as keeping harmful bacteria often found in wound fluid away from the wound.”